Zhimin Lu Selected Research

Non-Receptor Type 12 Protein Tyrosine Phosphatase

2/2013	Regulation of tumor cell migration by protein tyrosine phosphatase (PTP)-proline-, glutamate-, serine-,and threonine-rich sequence (PEST).
11/2011	Ras-induced and extracellular signal-regulated kinase 1 and 2 phosphorylation-dependent isomerization of protein tyrosine phosphatase (PTP)-PEST by PIN1 promotes FAK dephosphorylation by PTP-PEST.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhimin Lu Research Topics

Disease

72	Neoplasms (Cancer) 01/2022 - 12/2003
23	Carcinogenesis 01/2021 - 12/2011
16	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 11/2009
9	Brain Neoplasms (Brain Tumor) 01/2021 - 07/2011
7	Glioma (Gliomas) 01/2022 - 11/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
6	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2003
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2016
5	Hypoxia (Hypoxemia) 12/2019 - 03/2016
4	Breast Neoplasms (Breast Cancer) 08/2021 - 07/2011
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020 - 05/2012
2	Rheumatoid Arthritis 01/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 01/2021 - 12/2003
2	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2021
2	Infections 10/2020 - 01/2019
2	Lymphopenia (Lymphocytopenia) 10/2020 - 06/2019
2	Serositis 10/2020 - 01/2019
1	Adenocarcinoma of Lung 02/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Communicable Diseases (Infectious Diseases) 07/2021
1	Adenocarcinoma 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021

Drug/Important Bio-Agent (IBA)

17	EnzymesIBA 01/2022 - 10/2013
13	Protein Kinases (Protein Kinase)IBA 01/2021 - 08/2012
10	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2003
9	CateninsIBA 08/2021 - 07/2011
9	Epidermal Growth Factor (EGF)IBA 01/2021 - 12/2003
9	Pyruvate KinaseIBA 05/2015 - 12/2011
8	ErbB Receptors (EGF Receptor)IBA 08/2014 - 12/2003
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2012
7	Histones (Histone)IBA 01/2020 - 08/2012
7	Protein Isoforms (Isoforms)IBA 01/2020 - 12/2011
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2016
6	Phosphotransferases (Kinase)IBA 01/2021 - 05/2004
5	beta CateninIBA 11/2009 - 12/2003
4	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2022 - 03/2016
4	Glutamine (L-Glutamine)FDA Link 01/2022 - 03/2017
4	CytokinesIBA 12/2021 - 01/2013
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2012
4	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2018
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2012
3	MethyltransferasesIBA 01/2021 - 12/2012
3	PhosphoenolpyruvateIBA 01/2021 - 01/2020
3	LigandsIBA 01/2021 - 10/2019
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2014
3	Deoxyglucose (2 Deoxy D glucose)IBA 12/2018 - 10/2017
3	Proline (L-Proline)FDA Link 04/2016 - 02/2013
3	Caveolin 1IBA 07/2011 - 12/2003
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 04/2016
2	ChromatinIBA 01/2022 - 01/2017
2	Choline KinaseIBA 01/2022 - 10/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
2	AntibodiesIBA 01/2022 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2022 - 07/2013
2	Messenger RNA (mRNA)IBA 01/2021 - 10/2019
2	FructoseIBA 01/2021 - 01/2016
2	NADP (NADPH)IBA 01/2021 - 01/2018
2	LipidsIBA 01/2021 - 09/2014
2	Biological ProductsIBA 01/2021 - 10/2017
2	Phosphofructokinase-1 (Phosphofructokinase 1)IBA 01/2020 - 10/2017
2	SterolsIBA 01/2020 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 08/2014
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2019 - 09/2014
2	ketohexokinaseIBA 01/2019 - 01/2016
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 07/2009
2	fructokinaseIBA 01/2019 - 01/2016
2	Acetates (Acetic Acid Esters)FDA Link 10/2017 - 06/2017
2	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 12/2012
2	Serine (L-Serine)FDA Link 02/2013 - 07/2009
2	Non-Receptor Type 12 Protein Tyrosine PhosphataseIBA 02/2013 - 11/2011
2	Cyclin D1IBA 08/2012 - 01/2011
2	Glycogen Synthase Kinase 3 betaIBA 04/2008 - 05/2004
2	Cadherins (E-Cadherin)IBA 05/2004 - 12/2003
1	Complement System Proteins (Complement)IBA 01/2022
1	iguratimodIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	CarbonIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	glucose utilization inhibitor (IGU)IBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	Amino Acids FDA Link 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	ProteomeIBA 12/2021
1	Interleukin-27 (Interleukin 27)IBA 12/2021
1	TOR Serine-Threonine KinasesIBA 12/2021
1	Sorafenib (BAY 43-9006)FDA Link 11/2021
1	tanespimycin (17AAG)IBA 08/2021
1	Glycogen Synthase (Synthase I)IBA 08/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2021
1	InterleukinsIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Inosine Triphosphate (ITP)IBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	GlutaminaseIBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2021 - 03/2010
2	Immunotherapy 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 06/2016
1	Precision Medicine 07/2021